Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial-Reference-Cited by-同舟云学术

Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial

Published:1990-10 Issue:5 Volume:8 Page:457-461
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Storsaeter Jann,Hallander Hans,Farrington Conor P.,Olin Patrick,Möllby Roland,Miller Elizabeth

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Ad Hoc Group for the Study of Pertussis Vaccines,1988

2. Combined Scottish Study,1970

3. Reflections on the efficacy of pertussis vaccines;Fine;Rev. Infect. Dis.,1987

4. Efficacy of pertussis vaccination in England;Public Health Laboratory Service Epidemiological Research Laboratory and 21 area health authorities;Br. Med. J.,1982

5. A Clinical Trial of Acellular Pertussis Vaccines in Sweden,1988

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pertussis Vaccines;Plotkin's Vaccines;2023

2. Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups;Emerging Microbes & Infections;2022-03-30

3. Pertussis in Italy: how to protect the “unprotectable”?;Human Vaccines & Immunotherapeutics;2020-10-29

4. Modeling the waning and boosting of immunity from infection or vaccination;Journal of Theoretical Biology;2020-07

5. DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age;Expert Review of Vaccines;2019-11-02